Blood tests during electroconvulsive therapy
Part of Mental health clinical trials.
This study looks at blood markers (substances in blood) measured during electroconvulsive therapy, to understand how the treatment is working in the body. If you’re already being considered for ECT, you may be asked for blood samples as part of this research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You’ve been referred to the ECT clinic and have been accepted for ECT treatment
- You are able and willing to give informed consent (agree to join after learning the details)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study tests a way of adjusting (titrating) ECT treatment to improve outcomes in people with major depression or bipolar II. It’s mainly for those who already need ECT with right-side electrode placement.
This study compares two types of brain stimulation treatments—electroconvulsive therapy (ECT) and magnetic seizure therapy (MST)—to see which works better for people with certain mental health conditions. It may be an option if you have a mood disorder or vision problems that could be helped by these treatments.
This study checks how well electroconvulsive therapy (ECT) works for people with major depression right after treatment and again 6 months later. You may be able to take part if you had ECT for major depression at the specified hospitals and agree to be included in a neurostimulation follow-up registry.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study looks at brain wave patterns and markers of inflammation in people with depression that hasn't improved with other treatments and who are receiving electroconvulsive therapy (ECT, also known as shock therapy). The goal is to understand how these markers might relate to how well ECT works.
Hear when a new Electroconvulsive Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.